by Joan Rachlin, JD, MPH, Executive Director
Last week’s Food and Drug Administration approval of Truvada, the first drug to help prevent HIV infection in high-risk populations, was extraordinary, and extraordinarily well-timed. The announcement coincided with the opening of the 2012 International AIDS Conference, which was held in the US for the first time since President Obama lifted a travel and [...] Read more
After the commemoration of World AIDS Day last week, it’s encouraging to hear that researchers have found renewed hope and inspiration in the search for a cure. In this week's "Science Times" synthesis, learn about the new developments in HIV research, and share your thoughts on the current state of AIDS research and the potential impact of President Obama’s speech in which he committed to significant increases in funding.
Week of November 29
PRIM&R is pleased to bring you a live post from the second day of the 2011 Advancing Ethical Research Conference and the PRIM&R Blog Squad. The PRIM&R Blog Squad is composed of PRIM&R members who are devoted to blogging prior to, live from, and after our conferences.
Yesterday's quote of the day? “Sending a consent form to multiple institutional review boards (IRBs) for multiple separate tweaks is a bureaucracy that needs to be muzzled.”
Clearly, Robert Califf, MD, a speaker on Panel I—Increasing the Public’s Understanding of Clinical Research: Opportunities [...] Read more
by Elisa Hurley, PhD
Last week, the Presidential Commission for the Study of Bioethical Issues held its seventh public meeting in Boston. This was the final meeting devoted to President Obama’s charge to assess how well current regulations protect human subjects in research. The President’s instruction came in response to the revelation last year that from 1946 to 1948 the US Public Health [...] Read more
It’s been a busy week in the world of research ethics, and we wanted to take a minute to provide you with a list of a few news outlets where you can find out more about these current events.
On Monday, President Obama signed an executive order to lift the ban on embryonic stem cell research.
